EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Metabolic syndrome is associated with breast cancer mortality: A systematic review and meta‐analysis

Sixten Harborg iD, Helene Borup Larsen, Stine Elsgaard, Signe Borgquist iD

Journal of Internal Medicine · 2025-03 · 297 (3) · 262-275

DOI: 10.1111/joim.20052 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Internal Medicine, online erschienen am 08.01.2025. Verfasst von Sixten Harborg und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Aarhus University Hospital/Aarhus University, Aarhus, Denmark. Hauptthemen laut MEDLINE: Metabolic Syndrome, Breast Neoplasms. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institut for Klinisk Medicin, Aarhus Universitet.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This systematic review and meta‐analysis assesses the association between metabolic syndrome and breast cancer (BC) outcomes in BC survivors.

Methods

Systematic searches were carried out in PubMed and Embase using variations of the search terms: breast neoplasms (population), metabolic syndrome (exposure), and survival (outcome). Metabolic syndrome was characterized according to the American Heart Association, which includes the presence of three out of five abnormal findings among the risk factors: high blood pressure, high triglycerides, low high‐density lipoprotein, high fasting glucose, and central obesity. Data were obtained from observational studies and randomized controlled trials that utilized survival statistics and reported survival ratios to investigate how the presence of metabolic syndrome at the time of BC diagnosis is associated with BC outcomes. Study data were independently extracted by two authors, and effect sizes were pooled using random‐effects models.

Results

From the 1019 studies identified in the literature search, 17 were deemed eligible. These encompassed 42,135 BC survivors. The pooled estimates revealed that BC survivors who had metabolic syndrome at the time of their BC diagnosis experienced increased risk of recurrence (HR 1.69, 95% CI: 1.39–2.06), BC mortality (HR 1.83, 95% CI: 1.35–2.49), and shorter disease‐free survival (HR 1.57, 95% CI: 1.36–1.81) compared to BC survivors without metabolic syndrome.

Conclusions

Among BC survivors, metabolic syndrome was associated with inferior BC outcomes. This necessitates the creation of clinical guidelines that include metabolic screening for BC survivors. Further research should identify effective interventions to reduce the prevalence of metabolic syndrome among BC survivors to improve metabolic health and BC outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metabolic SyndromeBreast NeoplasmsHumansFemaleRisk FactorsCancer Survivors

Stichwörter der Autor:innen

breast neoplasmsmetabolic syndromemeta‐analysismortalityrecurrencereview

Autor:innen und Institutionen

  • Department of Oncology, Aarhus University Hospital/Aarhus University, Aarhus, Denmark.
  • Department of Clinical Epidemiology, Aarhus University Hospital/Aarhus University, Aarhus, Denmark.
  • Department of Clinical Sciences Lund, Oncology, Lund University, Lund, Sweden.

ORCID-Profile: Sixten Harborg, Signe Borgquist

Förderung

  • Institut for Klinisk Medicin, Aarhus Universitet

Zitieren

APA

Harborg, S., Larsen, H. B., Elsgaard, S., & Borgquist, S. (2025). Metabolic syndrome is associated with breast cancer mortality: A systematic review and meta‐analysis. Journal of Internal Medicine, 297(3), 262-275. https://doi.org/10.1111/joim.20052

Vancouver

Harborg S, Larsen HB, Elsgaard S, Borgquist S. Metabolic syndrome is associated with breast cancer mortality: A systematic review and meta‐analysis. Journal of Internal Medicine. 2025;297(3):262-275. doi:10.1111/joim.20052

BibTeX
@article{Harborg2025,
  author = {Harborg, Sixten and Larsen, Helene Borup and Elsgaard, Stine and Borgquist, Signe},
  title = {Metabolic syndrome is associated with breast cancer mortality: A systematic review and meta‐analysis},
  journal = {Journal of Internal Medicine},
  year = {2025},
  volume = {297},
  number = {3},
  pages = {262--275},
  doi = {10.1111/joim.20052}
}
Kostenlos starten →